Tackling Obesity
Insights on a pervasive global health challenge
Obesity, a pervasive global health challenge, transcends borders, impacting millions with profound consequences to their well-being and quality of life.
Obesity prevalence has been increasing over the past few decades, especially in Asia and Europe. Currently, the economic impact of obesity is estimated at $2Tn globally, and by 2035 approximately 25% of the global population could be classed as obese. This poses an escalating burden on healthcare systems worldwide, fostering the rise of cardiovascular risk factors, and chronic diseases including diabetes, kidney and liver diseases.
IQVIA works with policy makers, healthcare systems, payers, manufacturers and researchers to tackle the obesity epidemic, identifying key trends, researching strategies and developing thought leadership to move forward, as well as providing solutions ranging from clinical research, real world data, market access and healthcare system capacity development, commercialisation and monitoring.
Industry Insights
- May 2024 – When the dust settles: The future shape of the obesity market
- February 2024 - 2024: The obesity market’s inflection point?
- November 2023 - Beyond obesity: Novo’s SELECT re-defines cardiovascular risk management
- August 2023 - Novo’s SELECT trial delivers, with far-reaching implications for obesity
In this whitepaper, read about the latest trends in cardiometabolic breakthrough innovation, the market opportunity, and critical success factors for innovators; take a deep dive into the obesity market which is at a major inflection point.
The resilience of obesity diagnosis occurring despite the rising uptake of GLP-1s should serve as a positive general signal for MedTech industry players to counter investor concerns about the potential of reduced demand, or that the demand may be net-neutral, rather than a sudden decline.
The IQVIA Institute for Human Data Science offers a multi-stakeholder webinar to discuss the direct impacts of obesity on clinical practices and the economy of health systems.
Real-World Evidence for Obesity
In this blog series, we embark on an exploration through the diverse realm of obesity research, illuminated by Real-World Evidence (RWE). Our journey takes us beyond conventional approaches, blending intricate details of data collection with the evolving roles of technology, ethical considerations, and societal influences in the field of obesity. Each instalment is more than a mere presentation of facts; it is an in-depth narrative that invites a re-evaluation of how real-world data is utilized in healthcare.
Blueprint for success
IQVIA’s experts, thought leadership and solutions can provide the expertise and insights needed to understand the obesity landscape.
Fill in the form to talk to us today
